Kai-Suan Psychiatric Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2007
NCT01075529
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

amisulpride (BARHEMSYS) (1 trial)

fluoxetine (prozac) (1 trial)

risperidone (risperdal) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Schizophrenia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3